Skip to main content

Market Overview

Mid-Day Market Update: Steelcase Surges On Upbeat Q3 Results; Aduro BioTech Shares Plunge


Midway through trading Wednesday, the Dow traded up 0.04% to 28277.07 while the NASDAQ rose 0.22% to 8842.66. The S&P also rose, gaining 0.07% to 3,194.76.

Leading and Lagging Sectors

Real estate shares climbed 0.9% on Wednesday. Meanwhile, top gainers in the sector included Uniti Group Inc (NASDAQ: UNIT), up 13%, and Corecivic Inc (NYSE: CXW), up 3%.

In trading on Wednesday, materials shares fell 0.9%.

Top Headline

General Mills, Inc. (NYSE: GIS) reported better-than-expected earnings for its second quarter.

General Mills reported second-quarterly earnings of 95 cents per share on Wednesday, which beat the analyst consensus estimate of 88 cents. The company reported quarterly sales of $4.42 billion, which missed the analyst consensus estimate of $4.43 billion.

General Mills reaffirmed its full-year fiscal 2020 targets for sales, profit, and EPS, and raised its target for free cash flow conversion.

Equities Trading UP

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) shares shot up 60% to $26.42. Mirum Pharmaceuticals shares climbed 111% on Monday after the company announced it completed a successful pre-NDA meeting with the FDA for its Maralixibat.

Shares of Steelcase Inc. (NYSE: SCS) got a boost, shooting up 18% to $22.52 after the company reported better-than-expected Q3 EPS and sales results.

Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) shares were also up, gaining 22% to $5.65 after the company announced it has entered into a collaboration agreement with Global Blood Therapeutics to discover, develop, and commercialize novel therapies for sickle cell disease and beta thalassemia. GBT will pay Syros $20 million upfront and fund up to $40 million in preclinical research for at least three years.

Equities Trading DOWN

Qiwi plc (NASDAQ: QIWI) shares tumbled 12% to $18.69 after the company named Boris Kim as CEO, effective January 15. QIWI appointed Maria Shevchenko as Deputy CEO.

Shares of Aduro BioTech Inc (NASDAQ: ADRO) were down 13% to $1.00 after William Blair downgraded the stock from Outperform to Market Perform.

Solid Biosciences Inc. (NASDAQ: SLDB) was down, falling 14% to $4.13 following on an update on its clinical development program for its SGT-001, its gene transfer investigational candidate for Duchenne muscular dystrophy, or DMD.


In commodity news, oil traded down 0.1% to $60.91, while gold traded down 0.1% to $1,479.60.

Silver traded down 0.2% Wednesday to $17.035, while copper fell 0.3% to $2.805.

Euro zone

European shares were mostly lower today. The eurozone’s STOXX 600 declined 0.13%, the Spanish Ibex Index rose 0.08%, while Italy’s FTSE MIB Index slipped 0.01%. Meanwhile, the German DAX dropped 0.43%, and the French CAC 40 fell 0.02% while UK shares rose 0.21%.


U.S. crude supplies dropped 1.1 million barrels for the week ended December 13, the Energy Information Administration reported. However, analysts expected a decline of 2.5 million barrels. Gasoline supplies rose 2.5 million barrels, while distillate supplies gained 1.5 million barrels for the week.

Chicago Fed President Charles Evans will speak at 12:40 p.m. ET.


Related Articles (CXW + ADRO)

View Comments and Join the Discussion!

Posted-In: Mid-Day Market UpdateEarnings News Eurozone Commodities Global Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at